GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ovation Science Inc (XCNQ:OVAT) » Definitions » Revenue

Ovation Science (XCNQ:OVAT) Revenue : C$0.11 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ovation Science Revenue?

Ovation Science's revenue for the three months ended in Sep. 2024 was C$0.01 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.11 Mil. Ovation Science's Revenue per Share for the three months ended in Sep. 2024 was C$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.00.

Warning Sign:

Ovation Science Inc revenue per share has been in decline for the last 5 years.

During the past 3 years, the average Revenue per Share Growth Rate was -58.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was -26.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 7 years, Ovation Science's highest 3-Year average Revenue per Share Growth Rate was 10.10% per year. The lowest was -58.50% per year. And the median was -35.90% per year.


Ovation Science Revenue Historical Data

The historical data trend for Ovation Science's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovation Science Revenue Chart

Ovation Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial 0.30 0.75 0.23 0.14 0.06

Ovation Science Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.02 0.04 0.04 0.01

Competitive Comparison of Ovation Science's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ovation Science's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ovation Science's Revenue distribution charts can be found below:

* The bar in red indicates where Ovation Science's Revenue falls into.



Ovation Science Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ovation Science  (XCNQ:OVAT) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Ovation Science Revenue Related Terms

Thank you for viewing the detailed overview of Ovation Science's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ovation Science Business Description

Traded in Other Exchanges
Address
1166 Alberni Street, Suite 1003, Vancouver, BC, CAN, V6E 3Z3
Ovation Science Inc. is a Canada-based company mainly engaged in providing topical and transdermal cannabis products under the "Ovation" brand label. It utilizes the patented "Invisicare" delivery technology, which it acquired for exclusive use for cannabis-formulated products. The group has two geographical segments: Canada and the United States. Key revenue is generated from Canada.
Executives
Shane Dungey Director
Doreen Mcmorran Director
Ian Howard Director
David K. Ryan Director

Ovation Science Headlines

No Headlines